• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

High-efficacy DMTs in MS – the year in review

November 14, 2024  

Pregnancy and MS – new data from ECTRIMS

October 17, 2024  

ECTRIMS update on ofatumumab

October 11, 2024  

ECTRIMS 2024 HIGHLIGHTS – FRIDAY, SEPTEMBER 20, 2024

September 20, 2024  

ECTRIMS 2024 HIGHLIGHTS – THURSDAY, SEPTEMBER 19, 2024

September 19, 2024  

ECTRIMS 2024 HIGHLIGHTS – WEDNESDAY, SEPTEMBER 18, 2024

September 18, 2024  

Does MS burn out?

August 20, 2024  

Utility of biomarkers in progressive MS

August 1, 2024  

Protein biomarker panel useful for MS diagnosis, prognosis

July 23, 2024  

REPORT FROM EAN 2024 – THURSDAY, JULY 4, 2024

July 4, 2024  
Previous
4
5
6
7
8
Next

Browse by Topic

  • MS (445)
  • MSToronto2026 (1)
  • CLINICAL CASES (22)
  • EAN 2026 (2)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • CLINICAL CASES IN NEUROLOGY – A YOUNG WOMAN WITH MILD EARLY MS posted on September 17, 2026
  • Ofatumumab 2026 – update on real-world effectiveness posted on September 22, 2026
  • Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions